Page 363 - HIVMED_v21_i1.indb
P. 363

Southern African Journal of HIV Medicine
              ISSN: (Online) 2078-6751, (Print) 1608-9693
                                                       Page 1 of 8  Original Research


                      Cervical human papillomavirus prevalence, risk

                     factors and outcomes in a cohort of HIV-infected

                                      women in Harare, Zimbabwe






               Authors:                 Background: Human papillomavirus (HPV) associated invasive cervical cancer (ICC) is
               Ardele M. Mandiriri      common  in  Zimbabwe,  disproportionately  affecting  women  living  with  HIV  (WLHIV).
                           1,2
                           1
               Margaret J. Pascoe
               Tinei Shamu              Understanding high-risk HPV (hrHPV) infection in relation to cervical disease is important for
                       1,3
               Sara Lowe                ICC prevention amongst WLHIV.
                     1,4
               Affiliations:            Objectives: To describe the prevalence of cervical hrHPV, type distribution, associated risk
               1 Newlands Clinic, Harare,   factors and ICC screening outcomes in an urban cohort of Zimbabwean women.
               Zimbabwe
                                        Methods: In this cohort study, WLHIV were tested for hrHPV infection using the Cepheid
               2 Department of Epidemiology,   Xpert® HPV assay and followed up for incident cervical disease. Follow-up assessments were
               Faculty of Epidemiology and   done by visual inspection with acetic acid (VIA). Descriptive statistics and logistic regression
               Population Health, London
               School of Hygiene and    were used to describe hrHPV burden and association between hrHPV and potential risk
               Tropical Medicine, London,   factors. Incidence rates (IR) and rate ratios of cervical disease by hrHPV infection status were
               United Kingdom           also calculated.
               3 Institute of Social and   Results: Amongst 321 WLHIV recruited, hrHPV prevalence was 24.9% (n = 80). Fifty-two of
               Preventive Medicine,     these women (65%) were positive for hrHPV types other than 16 or 18/45. Younger age
               University of Bern, Bern,   (22–29 years), early sexual debut (13–16 years) and antiretroviral therapy (ART) regimen
               Switzerland
                                        (second-line ART) were independently associated with hrHPV positivity. Positive VIA IR
               4 Department of Medicine,   ratio  between hrHPV-positive and -negative women was 12.57 (95% confidence interval
               College of Health Sciences,   [CI]:  4.14–38.19). Only women with hrHPV infection had incident cervical disease
               University of Zimbabwe,   (IR: 6.41/100 person-years, (95% CI: 3.33–12.32). There were no ICC cases by the end of the
               Harare, Zimbabwe
                                        2-year follow-up.
               Corresponding author:    Conclusion: There was a high prevalence of hrHPV infection other than 16 and 18/45 in this
               Ardele Mandiriri,
               ArdeleM@newlandsclinic.  cohort. Integrating HPV testing in cervical cancer screening programmes may increase
               org.zw                   screening intervals in hrHPV-negative women, reducing costs for programmes. We recommend
                                        further research into cross protectivity of the bivalent and quadrivalent HPV vaccines against
               Dates:
               Received: 06 July 2020   these other hrHPV types.
               Accepted: 30 Aug. 2020
               Published: 05 Nov. 2020  Keywords: cervical cancer screening; HPV infection in WLHIV; hrHPV prevalence; visual
                                        inspection with acetic acid; HPV vaccine cross protection.
               How to cite this article:
               Mandiriri AM, Pascoe MJ.,
               Shamu T., Lowe S. Cervical   Introduction
               human papillomavirus
               prevalence, risk factors and   Zimbabwe is one of the countries with the highest human immunodeficiency virus (HIV) burden
               outcomes in a cohort of
               HIV-infected women in   in sub-Saharan Africa. In 2018, the HIV prevalence was estimated at 12.7% amongst adults aged
                                                                                                       1
               Harare, Zimbabwe. S Afr J HIV   15 to 49 years, with a higher prevalence in women (15.4%) than in men (10.0%).  Women living
               Med. 2020;21(1), a1123.   with HIV (WLHIV) have higher rates of infection with high-risk Human Papillomavirus (hrHPV)
               https://doi.org/10.4102/  genotypes. High-risk human papillomavirus co-infection with HIV is associated with decreased
               sajhivmed.v21i1.1123
                                       clearance, increased HPV persistence and progression to precancerous lesions and cervical
                                       cancer. 2,3,4,5  Invasive cervical cancer (ICC) is the most common female malignancy in Zimbabwe
                                       and is the leading cause of female cancer-related deaths with an age-standardised mortality rate
                                       of 46 per 100 000 women per year. 6


                                       The current recommended cervical cancer screening method in low resource settings such as sub-
               Read online:                                                                              7,8,9
               Read online:
                        Scan this QR
                        Scan this QR   Saharan Africa is visual inspection of the cervix after application of acetic acid (VIA).   The WHO
                        code with your
                        code with your   2013 cervical cancer guidelines recommend primary HPV testing as the preferred method where
                        smart phone or   resources are available, as HPV testing is more sensitive and effective in identifying women at
                        smart phone or
                        mobile device
                        mobile device
                        to read online.
                        to read online.
                                       Copyright: © 2020. The Authors. Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
                                           http://www.sajhivmed.org.za 355  Open Access
   358   359   360   361   362   363   364   365   366   367   368